Stimvia Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Series A
- (Cancelled)
- Investors
-
4
Stimvia General Information
Description
Developer of an electroceutical medical device designed to allow non-invasive treatment of chronic diseases using neuromodulation. The company's device provides optimizations of treatment parameters for personalized therapy to achieve an enhanced effect for each patient, goes beyond overactive bladders and is also used in treating other indicators such as infertility, migraine and cluster headache, erectile dysfunction and premature ejaculation, enabling patients to get access to effective electrochemical treatment.
Contact Information
Website
www.stimvia.comCorporate Office
- Technologická 376/5
- Pustkovec
- Ostrava, 708 00
- Czech Republic
Corporate Office
- Technologická 376/5
- Pustkovec
- Ostrava, 708 00
- Czech Republic
Stimvia Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series A) | 19-Jun-2025 | Cancelled | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 10-Oct-2024 | Completed | Clinical Trials - General | |||
| 4. Secondary Transaction - Private | 01-Oct-2021 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series A) | 02-Sep-2021 | Completed | Clinical Trials - General | |||
| 2. Accelerator/Incubator | 13-Jan-2021 | Completed | Startup | |||
| 1. Early Stage VC | 25-Apr-2018 | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Stimvia Patents
Stimvia Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260355515-A1 | Method and system for activating brain regions | Pending | 09-Jul-2026 | ||
| AU-2021300512-A1 | Selective neuromodulation apparatus | Active | 02-Jul-2020 | ||
| AU-2021300512-B2 | Selective neuromodulation apparatus | Active | 02-Jul-2020 | ||
| CA-3184306-A1 | Selective neuromodulation apparatus | Pending | 02-Jul-2020 | ||
| EP-3932473-A1 | Selective neuromodulation apparatus | Pending | 02-Jul-2020 | A61N1/36031 |
Stimvia Signals
Stimvia Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Endless Frontier Labs | Accelerator/Incubator | Minority | ||
| Purple Ventures (Brno) | Venture Capital | Minority | ||
| DEXIC Accelerator | Accelerator/Incubator | |||
| Xenocles | Corporation | Minority |
Stimvia FAQs
-
When was Stimvia founded?
Stimvia was founded in 2014.
-
Where is Stimvia headquartered?
Stimvia is headquartered in Ostrava, Czech Republic.
-
What is the size of Stimvia?
Stimvia has 15 total employees.
-
What industry is Stimvia in?
Stimvia’s primary industry is Therapeutic Devices.
-
Is Stimvia a private or public company?
Stimvia is a Private company.
-
What is Stimvia’s current revenue?
The current revenue for Stimvia is .
-
How much funding has Stimvia raised over time?
Stimvia has raised $247K.
-
Who are Stimvia’s investors?
Endless Frontier Labs, Purple Ventures (Brno), DEXIC Accelerator, and Xenocles have invested in Stimvia.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process